BioMimetic Therapeutics bone product trial disappoints, but stock climbs

Augment bone graft shows lower bone fusion vs autograft.    Commentary from HealthPointCapital...   http://ow.ly/uxmR Reuters...  http://ow.ly/ugnD BioMimetic Therapeutics press release...  http://ow.ly/ugoY...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top